Mesoblast (MESO) Interest Coverage Ratio Growth (1y) (2016 - 2023)
Mesoblast (MESO) Interest Coverage Ratio Growth (1y) (2016 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
21.15% |
| Mar 31, 2023 |
7.51% |
| Dec 31, 2022 |
-132.26% |
| Sep 30, 2022 |
-74.26% |
| Jun 30, 2022 |
-61.04% |
| Mar 31, 2022 |
210.27% |
| Dec 31, 2021 |
2,649.97% |
| Sep 30, 2021 |
8,364.58% |
| Jun 30, 2021 |
82.58% |
| Mar 31, 2021 |
94.28% |
| Dec 31, 2020 |
94.42% |
| Sep 30, 2020 |
98.26% |
| Jun 30, 2020 |
15,239.21% |
| Mar 31, 2020 |
-1,620.85% |
| Dec 31, 2019 |
20.72% |
| Sep 30, 2019 |
-176.95% |
| Jun 30, 2019 |
117.26% |
| Mar 31, 2019 |
105.40% |
| Dec 31, 2016 |
-30.45% |
